Literature DB >> 22327019

The role of α1 and α5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats.

Marija Milić1, Jovana Divljaković, Sundari Rallapalli, Michael L van Linn, Tamara Timić, James M Cook, Miroslav M Savić.   

Abstract

Benzodiazepines negatively affect motor coordination and balance and produce myorelaxation. The aim of the present study was to examine the extent to which populations of γ-aminobutyric acid A (GABAA) receptors containing α1 and α5 subunits contribute to these motor-impairing effects in rats. We used the nonselective agonist diazepam and the α1-selective agonist zolpidem, as well as nonselective, α1-subunit and α5-subunit-selective antagonists flumazenil, βCCt, and XLi093, respectively. Ataxia and muscle relaxation were assessed by rotarod and grip strength tests performed 20 min after intraperitoneal treatment. Diazepam (2 mg/kg) induced significant ataxia and muscle relaxation, which were completely prevented by pretreatment with flumazenil (10 mg/kg) and βCCt (20 mg/kg). XLi093 antagonized the myorelaxant, but not the ataxic actions of diazepam. All three doses of zolpidem (1, 2, and 5 mg/kg) produced ataxia, but only the highest dose (5 mg/kg) significantly decreased the grip strength. These effects of zolpidem were reversed by βCCt at doses of 5 and 10 mg/kg, respectively. The present study demonstrates that α1 GABAA receptors mediate ataxia and indirectly contribute to myorelaxation in rats, whereas α5 GABAA receptors contribute significantly, although not dominantly, to muscle relaxation but not ataxia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22327019      PMCID: PMC3296822          DOI: 10.1097/FBP.0b013e3283512c85

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  33 in total

1.  Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.

Authors:  Q Huang; X He; C Ma; R Liu; S Yu; C A Dayer; G R Wenger; R McKernan; J M Cook
Journal:  J Med Chem       Date:  2000-01-13       Impact factor: 7.446

Review 2.  Structure, pharmacology, and function of GABAA receptor subtypes.

Authors:  Werner Sieghart
Journal:  Adv Pharmacol       Date:  2006

3.  Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

Authors:  Miroslav M Savić; Dragan I Obradović; Nenad D Ugresić; James M Cook; P V V S Sarma; Dubravko R Bokonjić
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

4.  NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.

Authors:  N R Mirza; J S Larsen; C Mathiasen; T A Jacobsen; G Munro; H K Erichsen; A N Nielsen; K B Troelsen; E Ø Nielsen; P K Ahring
Journal:  J Pharmacol Exp Ther       Date:  2008-09-12       Impact factor: 4.030

5.  Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

Authors:  U Rudolph; F Crestani; D Benke; I Brünig; J A Benson; J M Fritschy; J R Martin; H Bluethmann; H Möhler
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

6.  Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

Authors:  R M McKernan; T W Rosahl; D S Reynolds; C Sur; K A Wafford; J R Atack; S Farrar; J Myers; G Cook; P Ferris; L Garrett; L Bristow; G Marshall; A Macaulay; N Brown; O Howell; K W Moore; R W Carling; L J Street; J L Castro; C I Ragan; G R Dawson; P J Whiting
Journal:  Nat Neurosci       Date:  2000-06       Impact factor: 24.884

Review 7.  GABAA receptor alpha2/alpha3 subtype-selective modulators as potential nonsedating anxiolytics.

Authors:  John R Atack
Journal:  Curr Top Behav Neurosci       Date:  2010

8.  The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats.

Authors:  Miroslav M Savić; Marija M Milinković; Sundari Rallapalli; Terry Clayton; Sroan Joksimović; Michael Van Linn; James M Cook
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-06       Impact factor: 5.176

9.  Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?

Authors:  Miroslav M Savić; Shengming Huang; Roman Furtmüller; Terry Clayton; Sigismund Huck; Dragan I Obradović; Nenad D Ugresić; Werner Sieghart; Dubravko R Bokonjić; James M Cook
Journal:  Neuropsychopharmacology       Date:  2007-03-28       Impact factor: 7.853

10.  Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys.

Authors:  Stephanie C Licata; Donna M Platt; James M Cook; Michael L Van Linn; James K Rowlett
Journal:  Psychopharmacology (Berl)       Date:  2008-11-25       Impact factor: 4.530

View more
  15 in total

1.  Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the α5 subunit.

Authors:  Tamara Timić Stamenić; Michael M Poe; Sabah Rehman; Anja Santrač; Branka Divović; Petra Scholze; Margot Ernst; James M Cook; Miroslav M Savić
Journal:  Eur J Pharmacol       Date:  2016-09-14       Impact factor: 4.432

Review 2.  The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.

Authors:  Amanda C Fitzgerald; Brittany T Wright; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

3.  The involvement of magnoflorine in the sedative and anxiolytic effects of Sinomeni Caulis et Rhizoma in mice.

Authors:  June Bryan I de la Peña; Hye Lim Lee; Seo Young Yoon; Gun Hee Kim; Yong Soo Lee; Jae Hoon Cheong
Journal:  J Nat Med       Date:  2013-03-03       Impact factor: 2.343

4.  Differential cerebellar GABAA receptor expression in mice with mutations in CaV2.1 (P/Q-type) calcium channels.

Authors:  S Kaja; A J Payne; E Ø Nielsen; C L Thompson; A M J M van den Maagdenberg; P Koulen; T P Snutch
Journal:  Neuroscience       Date:  2015-07-21       Impact factor: 3.590

5.  5-(N, N-Hexamethylene) amiloride is a GABA-A ρ1 receptor positive allosteric modulator.

Authors:  Heather D Snell; Eric B Gonzales
Journal:  Channels (Austin)       Date:  2016-07-01       Impact factor: 2.581

6.  Insights into functional pharmacology of α₁ GABA(A) receptors: how much does partial activation at the benzodiazepine site matter?

Authors:  Srđan Joksimović; Zdravko Varagic; Jovana Kovačević; Michael Van Linn; Marija Milić; Sundari Rallapalli; Tamara Timić; Werner Sieghart; James M Cook; Miroslav M Savić
Journal:  Psychopharmacology (Berl)       Date:  2013-05-18       Impact factor: 4.530

7.  Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects.

Authors:  Aleksandar Lj Obradović; Srđan Joksimović; Michael M Poe; Joachim Ramerstorfer; Zdravko Varagic; Ojas Namjoshi; Bojan Batinić; Tamara Radulović; Bojan Marković; Brian L Roth; Werner Sieghart; James M Cook; Miroslav M Savić
Journal:  Brain Res       Date:  2014-01-25       Impact factor: 3.252

8.  Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles.

Authors:  Thomas D Prevot; Guanguan Li; Aleksandra Vidojevic; Keith A Misquitta; Corey Fee; Anja Santrac; Daniel E Knutson; Michael Rajesh Stephen; Revathi Kodali; Nicolas M Zahn; Leggy A Arnold; Petra Scholze; Janet L Fisher; Bojan D Marković; Mounira Banasr; James M Cook; Miroslav Savic; Etienne Sibille
Journal:  Mol Neuropsychiatry       Date:  2019-01-23

9.  Blockade of α1 subtype GABAA receptors attenuates the development of tolerance to the antinociceptive effects of midazolam in rats.

Authors:  Lakeisha A Lewter; Lalit K Golani; James M Cook; Jun-Xu Li
Journal:  Behav Pharmacol       Date:  2021-06-01       Impact factor: 2.277

10.  GR3027 antagonizes GABAA receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy.

Authors:  Maja Johansson; Ana Agusti; Marta Llansola; Carmina Montoliu; Jessica Strömberg; Evgenya Malinina; Gianna Ragagnin; Magnus Doverskog; Torbjörn Bäckström; Vicente Felipo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.